Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

Globus Medical GMED has experienced strong upward momentum in the past year, with its shares rising 41.8%. This has far outpaced the industry’s 7.5% decline and the S&P 500 composite’s 8.8% growth.

The performance reflects the strong potential of the combined Globus-NuVasive organization and the growing value creation from the merger. Impressively, the company registered the highest ...

Globus Medical has been actively pursuing strategic acquisitions to enhance its market position and product offerings. The company successfully completed its merger with NuVasive (NASDAQ ...

Globus Medical has been actively pursuing strategic acquisitions to enhance its market position and product offerings. The company successfully completed its merger with NuVasive (NASDAQ:NUVA), ...

AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the ...

So we have that technology as does now Globus, formerly invasive has that technology ... Not to take too much from the history of NuVasive, but one of the challenges there was they were growing ...